Dental Local Anesthetic–Associated Vertigo During Extraction
Vertigo occurring immediately after a lidocaine injection should be treated as a possible early manifestation of local anesthetic systemic toxicity (LAST) or an inadvertent intravascular injection until proven otherwise.[1][2][3]
Dental extraction should not be continued while the patient remains symptomatic.[1][3][4]
Management Steps for Suspected LAST With Vertigo
Local anesthetic injection should be stopped immediately when symptoms of systemic toxicity occur.[1][3]
The patient should be positioned to support ventilation and safety during reassessment.[3][5]
Airway, breathing, and circulation should be managed with oxygen and supportive care.[1][5]
Immediate activation of emergency response and transfer to higher-acuity care should occur when systemic toxicity is suspected or symptoms do not rapidly resolve.[1][3][6]
Intravenous access should be established and vital signs should be monitored continuously until return to baseline.[3][4]
If seizures occur, benzodiazepines should be administered as part of LAST management.[1][3]
If cardiovascular instability or severe LAST is suspected, 20% lipid emulsion therapy should be initiated following established LAST protocols.[1][3][6]
Monitoring and Criteria to Resume the Dental Procedure
Patients with suspected intravascular injection–related symptoms should be monitored until level of consciousness and vital signs have returned to baseline.[4]
Resumption of any further local anesthetic dosing or continuation of the procedure should be deferred until symptoms have fully resolved and the patient has stabilized.[3][4]
If symptoms recur with additional dosing attempts, further administration should be avoided and escalation to emergency care should be pursued.[1][3]
Medication and Intervention Considerations
Intravascular injection–related presentations can include dizziness and vertigo and may improve with redistribution if symptoms remain mild.[4]
Persistent or worsening neurologic symptoms should be managed using the LAST approach rather than reassurance alone.[1][3]
Propofol should not be used as a substitute for benzodiazepines for seizure control in LAST when cardiovascular compromise is present.[1]
Practical Procedural Safeguards for Future Appointments
Technique should be reassessed to reduce inadvertent intravascular injection risk, including aspiration before injection and administration in incremental doses where appropriate.[3][7]
Re-exposure with local anesthetic should occur only after medical stabilization and a determination that the prior reaction was not progressing or consistent with significant systemic toxicity.[1][3]
Common Pitfalls to Avoid
Proceeding with the dental procedure during ongoing vertigo should be avoided because symptoms may represent early LAST.[1][3]
Under-recognition of mild early symptoms as “anxiety” can delay definitive LAST treatment steps such as supportive care and escalation.[1][3]
Not having lipid emulsion readily available is a preventable systems failure in settings where potentially cardiotoxic dosing is possible.[3][6]
Key References for Recommended Approach
The ASRA practice advisory on LAST outlines prevention, recognition, and treatment steps including stopping the inciting anesthetic administration and initiating appropriate supportive care and lipid emulsion therapy when indicated.[1]
FDA labeling for lidocaine products used in head and neck including dental blocks describes that adverse reactions can resemble systemic toxicity from unintentional intravascular injection.[2]
Specialist Pharmacy Service guidance for dental local anesthetic injection reactions notes that when toxicity-type symptoms occur, supportive monitoring should continue until the patient returns to baseline.[3][4]
Proceeding with extraction should be deferred until stability is achieved and systemic toxicity has been reasonably excluded or treated per LAST guidance.[1][3][4]